JAMA Dermatology: The Year in Review, 2021

    March 2022 in “ JAMA Dermatology ”
    Kanade Shinkai
    Image of study
    TLDR In 2021, JAMA Dermatology published significant findings on skin conditions post-COVID vaccination, melanoma surveillance, atopic dermatitis treatments, and confirmed that sun protection does not harm bone health.
    In 2021, JAMA Dermatology received 2903 article submissions, with 45% being research articles. The acceptance rate was 10% for research articles, and the journal reduced the median days of acceptance to publication to 57 days. The journal's impact factor increased to 10.3, and it had over 4.7 million article views and downloads. Notable publications included a study on neutrophilic facial dermatosis following COVID-19 vaccination, a pilot study on patient-led surveillance after treatment of localized melanoma, and a clinical trial showing the Janus kinase inhibitor upadacitinib had better efficacy for treating moderate-to-severe atopic dermatitis than dupilumab. The journal also reported a study showing sun-protective behaviors were not associated with diminished bone mineral density or increased prevalence of osteoporotic bone fractures. The journal is committed to improving diversity, equity, and inclusion within the network and in medical publishing.
    Discuss this study in the Community →

    Related Community Posts Join

    1 / 1 results
      Diffuse hair loss and scalp biopsies

      community Diffuse hair loss and scalp biopsies

      in Research  692 upvotes 3 months ago
      Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

    Similar Research

    5 / 1000+ results